nodes	percent_of_prediction	percent_of_DWPC	metapath
Conjugated Estrogens—ABCC1—Vemurafenib—melanoma	0.109	0.177	CbGbCtD
Conjugated Estrogens—ABCB1—melanoma	0.0952	1	CbGaD
Conjugated Estrogens—ABCG2—Vemurafenib—melanoma	0.0727	0.119	CbGbCtD
Conjugated Estrogens—ABCC1—Dactinomycin—melanoma	0.0722	0.118	CbGbCtD
Conjugated Estrogens—SLCO1B3—Docetaxel—melanoma	0.0539	0.088	CbGbCtD
Conjugated Estrogens—ABCG2—Dactinomycin—melanoma	0.0483	0.0788	CbGbCtD
Conjugated Estrogens—CYP1A2—Carmustine—melanoma	0.0379	0.0619	CbGbCtD
Conjugated Estrogens—ABCC1—Docetaxel—melanoma	0.0373	0.0608	CbGbCtD
Conjugated Estrogens—CYP1A2—Vemurafenib—melanoma	0.03	0.0489	CbGbCtD
Conjugated Estrogens—CYP3A4—Temozolomide—melanoma	0.0287	0.0468	CbGbCtD
Conjugated Estrogens—ABCC2—Docetaxel—melanoma	0.0276	0.045	CbGbCtD
Conjugated Estrogens—ABCG2—Docetaxel—melanoma	0.025	0.0407	CbGbCtD
Conjugated Estrogens—CYP1A2—Dacarbazine—melanoma	0.023	0.0375	CbGbCtD
Conjugated Estrogens—ABCB1—Dactinomycin—melanoma	0.0174	0.0284	CbGbCtD
Conjugated Estrogens—CYP3A4—Vemurafenib—melanoma	0.0157	0.0256	CbGbCtD
Conjugated Estrogens—ABCB1—Docetaxel—melanoma	0.009	0.0147	CbGbCtD
Conjugated Estrogens—CYP3A4—Docetaxel—melanoma	0.00539	0.0088	CbGbCtD
Conjugated Estrogens—Estramustine—MAP2—melanoma	0.00245	0.548	CrCbGaD
Conjugated Estrogens—SLC22A8—optic choroid—melanoma	0.00194	0.113	CbGeAlD
Conjugated Estrogens—COMT—hair follicle—melanoma	0.000969	0.0565	CbGeAlD
Conjugated Estrogens—ESR2—neck—melanoma	0.000682	0.0398	CbGeAlD
Conjugated Estrogens—ABCC1—hair follicle—melanoma	0.000673	0.0393	CbGeAlD
Conjugated Estrogens—SLC51A—head—melanoma	0.000665	0.0388	CbGeAlD
Conjugated Estrogens—ESR1—blood vessel—melanoma	0.000653	0.0381	CbGeAlD
Conjugated Estrogens—SLCO3A1—retina—melanoma	0.000622	0.0363	CbGeAlD
Conjugated Estrogens—SLCO4A1—retina—melanoma	0.000567	0.0331	CbGeAlD
Conjugated Estrogens—SLCO3A1—mammalian vulva—melanoma	0.000498	0.0291	CbGeAlD
Conjugated Estrogens—COMT—eye—melanoma	0.000483	0.0282	CbGeAlD
Conjugated Estrogens—ESR1—neck—melanoma	0.000467	0.0272	CbGeAlD
Conjugated Estrogens—SLC51A—lymph node—melanoma	0.000465	0.0272	CbGeAlD
Conjugated Estrogens—SLCO4A1—mammalian vulva—melanoma	0.000454	0.0265	CbGeAlD
Conjugated Estrogens—SLC10A1—head—melanoma	0.000431	0.0251	CbGeAlD
Conjugated Estrogens—Estrone—CYP1B1—melanoma	0.000425	0.0949	CrCbGaD
Conjugated Estrogens—COMT—skin of body—melanoma	0.000421	0.0245	CbGeAlD
Conjugated Estrogens—SLCO1C1—head—melanoma	0.000405	0.0236	CbGeAlD
Conjugated Estrogens—SLC22A8—eye—melanoma	0.000391	0.0228	CbGeAlD
Conjugated Estrogens—COMT—mammalian vulva—melanoma	0.000384	0.0224	CbGeAlD
Conjugated Estrogens—Depression—Carmustine—melanoma	0.000361	0.00263	CcSEcCtD
Conjugated Estrogens—Sepsis—Docetaxel—melanoma	0.000361	0.00263	CcSEcCtD
Conjugated Estrogens—Weight increased—Temozolomide—melanoma	0.000357	0.0026	CcSEcCtD
Conjugated Estrogens—SLCO3A1—head—melanoma	0.000356	0.0208	CbGeAlD
Conjugated Estrogens—Renal failure—Carmustine—melanoma	0.000356	0.0026	CcSEcCtD
Conjugated Estrogens—Neuropathy peripheral—Carmustine—melanoma	0.000355	0.00259	CcSEcCtD
Conjugated Estrogens—Hyperglycaemia—Temozolomide—melanoma	0.000354	0.00258	CcSEcCtD
Conjugated Estrogens—Phlebitis—Docetaxel—melanoma	0.00035	0.00256	CcSEcCtD
Conjugated Estrogens—Infestation NOS—Temozolomide—melanoma	0.00035	0.00255	CcSEcCtD
Conjugated Estrogens—Infestation—Temozolomide—melanoma	0.00035	0.00255	CcSEcCtD
Conjugated Estrogens—Depression—Temozolomide—melanoma	0.000349	0.00254	CcSEcCtD
Conjugated Estrogens—Thrombophlebitis—Docetaxel—melanoma	0.000349	0.00254	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Vemurafenib—melanoma	0.000345	0.00252	CcSEcCtD
Conjugated Estrogens—Pharyngitis—Dactinomycin—melanoma	0.000344	0.00251	CcSEcCtD
Conjugated Estrogens—Neuropathy peripheral—Temozolomide—melanoma	0.000343	0.0025	CcSEcCtD
Conjugated Estrogens—Swelling—Docetaxel—melanoma	0.000342	0.0025	CcSEcCtD
Conjugated Estrogens—Cardiac failure congestive—Docetaxel—melanoma	0.000333	0.00243	CcSEcCtD
Conjugated Estrogens—Hepatobiliary disease—Temozolomide—melanoma	0.000331	0.00241	CcSEcCtD
Conjugated Estrogens—Alopecia—Bleomycin—melanoma	0.000329	0.0024	CcSEcCtD
Conjugated Estrogens—Erythema multiforme—Dactinomycin—melanoma	0.000328	0.00239	CcSEcCtD
Conjugated Estrogens—Sinusitis—Temozolomide—melanoma	0.000328	0.00239	CcSEcCtD
Conjugated Estrogens—SLCO4A1—head—melanoma	0.000325	0.0189	CbGeAlD
Conjugated Estrogens—Erythema—Bleomycin—melanoma	0.000324	0.00236	CcSEcCtD
Conjugated Estrogens—Hypoaesthesia—Carmustine—melanoma	0.000323	0.00236	CcSEcCtD
Conjugated Estrogens—Estradiol—CYP1B1—melanoma	0.000322	0.0719	CrCbGaD
Conjugated Estrogens—Hypersensitivity—Vemurafenib—melanoma	0.000322	0.00235	CcSEcCtD
Conjugated Estrogens—Oedema peripheral—Carmustine—melanoma	0.00032	0.00234	CcSEcCtD
Conjugated Estrogens—Visual disturbance—Docetaxel—melanoma	0.000318	0.00232	CcSEcCtD
Conjugated Estrogens—Renal impairment—Docetaxel—melanoma	0.000317	0.00231	CcSEcCtD
Conjugated Estrogens—Dermatitis bullous—Docetaxel—melanoma	0.000316	0.0023	CcSEcCtD
Conjugated Estrogens—Asthenia—Vemurafenib—melanoma	0.000313	0.00228	CcSEcCtD
Conjugated Estrogens—Visual impairment—Carmustine—melanoma	0.000313	0.00228	CcSEcCtD
Conjugated Estrogens—Hypoaesthesia—Temozolomide—melanoma	0.000312	0.00228	CcSEcCtD
Conjugated Estrogens—Pharyngitis—Temozolomide—melanoma	0.000312	0.00227	CcSEcCtD
Conjugated Estrogens—Oedema peripheral—Temozolomide—melanoma	0.000309	0.00226	CcSEcCtD
Conjugated Estrogens—Pruritus—Vemurafenib—melanoma	0.000309	0.00225	CcSEcCtD
Conjugated Estrogens—Alopecia—Dactinomycin—melanoma	0.000307	0.00224	CcSEcCtD
Conjugated Estrogens—Eye disorder—Carmustine—melanoma	0.000304	0.00222	CcSEcCtD
Conjugated Estrogens—Visual impairment—Temozolomide—melanoma	0.000303	0.00221	CcSEcCtD
Conjugated Estrogens—Erythema—Dactinomycin—melanoma	0.000302	0.0022	CcSEcCtD
Conjugated Estrogens—Pain in extremity—Docetaxel—melanoma	0.000302	0.0022	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Vemurafenib—melanoma	0.000299	0.00218	CcSEcCtD
Conjugated Estrogens—Migraine—Docetaxel—melanoma	0.000297	0.00217	CcSEcCtD
Conjugated Estrogens—Erythema multiforme—Temozolomide—melanoma	0.000297	0.00217	CcSEcCtD
Conjugated Estrogens—Eye disorder—Temozolomide—melanoma	0.000293	0.00214	CcSEcCtD
Conjugated Estrogens—Cardiac disorder—Temozolomide—melanoma	0.000291	0.00213	CcSEcCtD
Conjugated Estrogens—Arrhythmia—Carmustine—melanoma	0.00029	0.00212	CcSEcCtD
Conjugated Estrogens—Dizziness—Vemurafenib—melanoma	0.000289	0.00211	CcSEcCtD
Conjugated Estrogens—ESR2—head—melanoma	0.000288	0.0168	CbGeAlD
Conjugated Estrogens—Alopecia—Carmustine—melanoma	0.000287	0.00209	CcSEcCtD
Conjugated Estrogens—Angiopathy—Temozolomide—melanoma	0.000285	0.00208	CcSEcCtD
Conjugated Estrogens—Mental disorder—Carmustine—melanoma	0.000285	0.00208	CcSEcCtD
Conjugated Estrogens—SLCO1C1—lymph node—melanoma	0.000284	0.0165	CbGeAlD
Conjugated Estrogens—Immune system disorder—Temozolomide—melanoma	0.000284	0.00207	CcSEcCtD
Conjugated Estrogens—Mediastinal disorder—Temozolomide—melanoma	0.000283	0.00206	CcSEcCtD
Conjugated Estrogens—Malnutrition—Carmustine—melanoma	0.000283	0.00206	CcSEcCtD
Conjugated Estrogens—Erythema—Carmustine—melanoma	0.000283	0.00206	CcSEcCtD
Conjugated Estrogens—Cough—Bleomycin—melanoma	0.000283	0.00206	CcSEcCtD
Conjugated Estrogens—Dehydration—Docetaxel—melanoma	0.000281	0.00205	CcSEcCtD
Conjugated Estrogens—Vomiting—Vemurafenib—melanoma	0.000277	0.00202	CcSEcCtD
Conjugated Estrogens—Alopecia—Temozolomide—melanoma	0.000277	0.00202	CcSEcCtD
Conjugated Estrogens—Chest pain—Bleomycin—melanoma	0.000276	0.00201	CcSEcCtD
Conjugated Estrogens—Myalgia—Bleomycin—melanoma	0.000276	0.00201	CcSEcCtD
Conjugated Estrogens—Rash—Vemurafenib—melanoma	0.000275	0.00201	CcSEcCtD
Conjugated Estrogens—Mental disorder—Temozolomide—melanoma	0.000275	0.00201	CcSEcCtD
Conjugated Estrogens—Dermatitis—Vemurafenib—melanoma	0.000275	0.00201	CcSEcCtD
Conjugated Estrogens—COMT—head—melanoma	0.000274	0.016	CbGeAlD
Conjugated Estrogens—Back pain—Carmustine—melanoma	0.000274	0.002	CcSEcCtD
Conjugated Estrogens—Headache—Vemurafenib—melanoma	0.000273	0.00199	CcSEcCtD
Conjugated Estrogens—Malnutrition—Temozolomide—melanoma	0.000273	0.00199	CcSEcCtD
Conjugated Estrogens—Erythema—Temozolomide—melanoma	0.000273	0.00199	CcSEcCtD
Conjugated Estrogens—Breast disorder—Docetaxel—melanoma	0.000273	0.00199	CcSEcCtD
Conjugated Estrogens—Cramp muscle—Docetaxel—melanoma	0.000272	0.00198	CcSEcCtD
Conjugated Estrogens—ABCC3—head—melanoma	0.000271	0.0158	CbGeAlD
Conjugated Estrogens—Dysgeusia—Temozolomide—melanoma	0.000268	0.00195	CcSEcCtD
Conjugated Estrogens—ABCC1—mammalian vulva—melanoma	0.000267	0.0156	CbGeAlD
Conjugated Estrogens—Vision blurred—Carmustine—melanoma	0.000267	0.00194	CcSEcCtD
Conjugated Estrogens—Anaphylactic shock—Bleomycin—melanoma	0.000264	0.00193	CcSEcCtD
Conjugated Estrogens—Oedema—Bleomycin—melanoma	0.000264	0.00193	CcSEcCtD
Conjugated Estrogens—Back pain—Temozolomide—melanoma	0.000264	0.00193	CcSEcCtD
Conjugated Estrogens—Infection—Bleomycin—melanoma	0.000263	0.00192	CcSEcCtD
Conjugated Estrogens—Dysphagia—Docetaxel—melanoma	0.000261	0.0019	CcSEcCtD
Conjugated Estrogens—Nausea—Vemurafenib—melanoma	0.000259	0.00189	CcSEcCtD
Conjugated Estrogens—ABCB1—blood vessel—melanoma	0.000258	0.015	CbGeAlD
Conjugated Estrogens—Vision blurred—Temozolomide—melanoma	0.000258	0.00188	CcSEcCtD
Conjugated Estrogens—Myalgia—Dactinomycin—melanoma	0.000257	0.00188	CcSEcCtD
Conjugated Estrogens—Bronchospasm—Docetaxel—melanoma	0.000257	0.00187	CcSEcCtD
Conjugated Estrogens—Estriol—ABCB1—melanoma	0.000256	0.0572	CrCbGaD
Conjugated Estrogens—SLCO2B1—head—melanoma	0.000253	0.0147	CbGeAlD
Conjugated Estrogens—Anorexia—Bleomycin—melanoma	0.000252	0.00184	CcSEcCtD
Conjugated Estrogens—Angioedema—Temozolomide—melanoma	0.00025	0.00182	CcSEcCtD
Conjugated Estrogens—SLCO3A1—lymph node—melanoma	0.000249	0.0146	CbGeAlD
Conjugated Estrogens—Hypotension—Bleomycin—melanoma	0.000247	0.0018	CcSEcCtD
Conjugated Estrogens—Oedema—Dactinomycin—melanoma	0.000247	0.0018	CcSEcCtD
Conjugated Estrogens—Vertigo—Temozolomide—melanoma	0.000246	0.00179	CcSEcCtD
Conjugated Estrogens—Convulsion—Carmustine—melanoma	0.000245	0.00179	CcSEcCtD
Conjugated Estrogens—Infection—Dactinomycin—melanoma	0.000245	0.00179	CcSEcCtD
Conjugated Estrogens—Palpitations—Temozolomide—melanoma	0.000242	0.00176	CcSEcCtD
Conjugated Estrogens—Musculoskeletal discomfort—Bleomycin—melanoma	0.000241	0.00176	CcSEcCtD
Conjugated Estrogens—Chest pain—Carmustine—melanoma	0.000241	0.00176	CcSEcCtD
Conjugated Estrogens—Myalgia—Carmustine—melanoma	0.000241	0.00176	CcSEcCtD
Conjugated Estrogens—Anxiety—Carmustine—melanoma	0.00024	0.00175	CcSEcCtD
Conjugated Estrogens—Cough—Temozolomide—melanoma	0.000238	0.00174	CcSEcCtD
Conjugated Estrogens—Estramustine—ABCB1—melanoma	0.000238	0.0532	CrCbGaD
Conjugated Estrogens—Paraesthesia—Bleomycin—melanoma	0.000237	0.00173	CcSEcCtD
Conjugated Estrogens—Weight increased—Docetaxel—melanoma	0.000237	0.00173	CcSEcCtD
Conjugated Estrogens—Convulsion—Temozolomide—melanoma	0.000237	0.00173	CcSEcCtD
Conjugated Estrogens—Dyspnoea—Bleomycin—melanoma	0.000236	0.00172	CcSEcCtD
Conjugated Estrogens—Anorexia—Dactinomycin—melanoma	0.000235	0.00172	CcSEcCtD
Conjugated Estrogens—Arthralgia—Temozolomide—melanoma	0.000233	0.0017	CcSEcCtD
Conjugated Estrogens—Myalgia—Temozolomide—melanoma	0.000233	0.0017	CcSEcCtD
Conjugated Estrogens—Infestation NOS—Docetaxel—melanoma	0.000233	0.0017	CcSEcCtD
Conjugated Estrogens—Infestation—Docetaxel—melanoma	0.000233	0.0017	CcSEcCtD
Conjugated Estrogens—SLCO1A2—head—melanoma	0.000232	0.0136	CbGeAlD
Conjugated Estrogens—Anxiety—Temozolomide—melanoma	0.000232	0.00169	CcSEcCtD
Conjugated Estrogens—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000231	0.00169	CcSEcCtD
Conjugated Estrogens—Oedema—Carmustine—melanoma	0.000231	0.00168	CcSEcCtD
Conjugated Estrogens—Decreased appetite—Bleomycin—melanoma	0.00023	0.00168	CcSEcCtD
Conjugated Estrogens—Infection—Carmustine—melanoma	0.000229	0.00167	CcSEcCtD
Conjugated Estrogens—Acute coronary syndrome—Docetaxel—melanoma	0.000229	0.00167	CcSEcCtD
Conjugated Estrogens—Renal failure—Docetaxel—melanoma	0.000229	0.00167	CcSEcCtD
Conjugated Estrogens—Myocardial infarction—Docetaxel—melanoma	0.000228	0.00166	CcSEcCtD
Conjugated Estrogens—Neuropathy peripheral—Docetaxel—melanoma	0.000228	0.00166	CcSEcCtD
Conjugated Estrogens—SLCO4A1—lymph node—melanoma	0.000227	0.0133	CbGeAlD
Conjugated Estrogens—Pain—Bleomycin—melanoma	0.000226	0.00165	CcSEcCtD
Conjugated Estrogens—Tachycardia—Carmustine—melanoma	0.000225	0.00164	CcSEcCtD
Conjugated Estrogens—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000225	0.00164	CcSEcCtD
Conjugated Estrogens—ABCC4—head—melanoma	0.000224	0.013	CbGeAlD
Conjugated Estrogens—Oedema—Temozolomide—melanoma	0.000223	0.00163	CcSEcCtD
Conjugated Estrogens—Anaphylactic shock—Temozolomide—melanoma	0.000223	0.00163	CcSEcCtD
Conjugated Estrogens—SLC22A8—head—melanoma	0.000222	0.0129	CbGeAlD
Conjugated Estrogens—Infection—Temozolomide—melanoma	0.000222	0.00162	CcSEcCtD
Conjugated Estrogens—ABCG2—mammalian vulva—melanoma	0.000221	0.0129	CbGeAlD
Conjugated Estrogens—Anorexia—Carmustine—melanoma	0.00022	0.00161	CcSEcCtD
Conjugated Estrogens—Hepatobiliary disease—Docetaxel—melanoma	0.00022	0.0016	CcSEcCtD
Conjugated Estrogens—Nervous system disorder—Temozolomide—melanoma	0.000219	0.0016	CcSEcCtD
Conjugated Estrogens—Skin disorder—Temozolomide—melanoma	0.000217	0.00158	CcSEcCtD
Conjugated Estrogens—Hypotension—Carmustine—melanoma	0.000216	0.00157	CcSEcCtD
Conjugated Estrogens—Hyperhidrosis—Temozolomide—melanoma	0.000216	0.00157	CcSEcCtD
Conjugated Estrogens—Decreased appetite—Dactinomycin—melanoma	0.000214	0.00156	CcSEcCtD
Conjugated Estrogens—Fatigue—Dactinomycin—melanoma	0.000213	0.00155	CcSEcCtD
Conjugated Estrogens—Anorexia—Temozolomide—melanoma	0.000213	0.00155	CcSEcCtD
Conjugated Estrogens—Pain—Dactinomycin—melanoma	0.000211	0.00154	CcSEcCtD
Conjugated Estrogens—Musculoskeletal discomfort—Carmustine—melanoma	0.00021	0.00153	CcSEcCtD
Conjugated Estrogens—Urticaria—Bleomycin—melanoma	0.00021	0.00153	CcSEcCtD
Conjugated Estrogens—Rhinitis—Docetaxel—melanoma	0.000209	0.00153	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Bleomycin—melanoma	0.000209	0.00153	CcSEcCtD
Conjugated Estrogens—Insomnia—Carmustine—melanoma	0.000209	0.00152	CcSEcCtD
Conjugated Estrogens—Hypoaesthesia—Docetaxel—melanoma	0.000208	0.00152	CcSEcCtD
Conjugated Estrogens—Paraesthesia—Carmustine—melanoma	0.000207	0.00151	CcSEcCtD
Conjugated Estrogens—Pharyngitis—Docetaxel—melanoma	0.000207	0.00151	CcSEcCtD
Conjugated Estrogens—Dyspnoea—Carmustine—melanoma	0.000206	0.0015	CcSEcCtD
Conjugated Estrogens—Oedema peripheral—Docetaxel—melanoma	0.000206	0.0015	CcSEcCtD
Conjugated Estrogens—Estropipate—ALB—melanoma	0.000205	0.0459	CrCbGaD
Conjugated Estrogens—Somnolence—Carmustine—melanoma	0.000205	0.0015	CcSEcCtD
Conjugated Estrogens—Musculoskeletal discomfort—Temozolomide—melanoma	0.000203	0.00148	CcSEcCtD
Conjugated Estrogens—Insomnia—Temozolomide—melanoma	0.000202	0.00147	CcSEcCtD
Conjugated Estrogens—Gastrointestinal pain—Dactinomycin—melanoma	0.000202	0.00147	CcSEcCtD
Conjugated Estrogens—ESR2—lymph node—melanoma	0.000202	0.0118	CbGeAlD
Conjugated Estrogens—Visual impairment—Docetaxel—melanoma	0.000201	0.00147	CcSEcCtD
Conjugated Estrogens—Decreased appetite—Carmustine—melanoma	0.000201	0.00146	CcSEcCtD
Conjugated Estrogens—Paraesthesia—Temozolomide—melanoma	0.0002	0.00146	CcSEcCtD
Conjugated Estrogens—Gastrointestinal disorder—Carmustine—melanoma	0.000199	0.00145	CcSEcCtD
Conjugated Estrogens—Dyspnoea—Temozolomide—melanoma	0.000199	0.00145	CcSEcCtD
Conjugated Estrogens—Somnolence—Temozolomide—melanoma	0.000198	0.00145	CcSEcCtD
Conjugated Estrogens—Erythema multiforme—Docetaxel—melanoma	0.000197	0.00144	CcSEcCtD
Conjugated Estrogens—Pain—Carmustine—melanoma	0.000197	0.00144	CcSEcCtD
Conjugated Estrogens—Constipation—Carmustine—melanoma	0.000197	0.00144	CcSEcCtD
Conjugated Estrogens—ESR1—head—melanoma	0.000197	0.0115	CbGeAlD
Conjugated Estrogens—Dyspepsia—Temozolomide—melanoma	0.000196	0.00143	CcSEcCtD
Conjugated Estrogens—Eye disorder—Docetaxel—melanoma	0.000195	0.00142	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Dactinomycin—melanoma	0.000195	0.00142	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Dactinomycin—melanoma	0.000195	0.00142	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Bleomycin—melanoma	0.000195	0.00142	CcSEcCtD
Conjugated Estrogens—Decreased appetite—Temozolomide—melanoma	0.000194	0.00141	CcSEcCtD
Conjugated Estrogens—Cardiac disorder—Docetaxel—melanoma	0.000194	0.00141	CcSEcCtD
Conjugated Estrogens—Gastrointestinal disorder—Temozolomide—melanoma	0.000193	0.00141	CcSEcCtD
Conjugated Estrogens—Fatigue—Temozolomide—melanoma	0.000192	0.0014	CcSEcCtD
Conjugated Estrogens—COMT—lymph node—melanoma	0.000192	0.0112	CbGeAlD
Conjugated Estrogens—Constipation—Temozolomide—melanoma	0.000191	0.00139	CcSEcCtD
Conjugated Estrogens—Pain—Temozolomide—melanoma	0.000191	0.00139	CcSEcCtD
Conjugated Estrogens—ABCC3—lymph node—melanoma	0.00019	0.0111	CbGeAlD
Conjugated Estrogens—Asthenia—Bleomycin—melanoma	0.00019	0.00138	CcSEcCtD
Conjugated Estrogens—Angiopathy—Docetaxel—melanoma	0.000189	0.00138	CcSEcCtD
Conjugated Estrogens—Gastrointestinal pain—Carmustine—melanoma	0.000189	0.00138	CcSEcCtD
Conjugated Estrogens—Immune system disorder—Docetaxel—melanoma	0.000189	0.00138	CcSEcCtD
Conjugated Estrogens—Mediastinal disorder—Docetaxel—melanoma	0.000188	0.00137	CcSEcCtD
Conjugated Estrogens—Pruritus—Bleomycin—melanoma	0.000187	0.00137	CcSEcCtD
Conjugated Estrogens—Arrhythmia—Docetaxel—melanoma	0.000187	0.00136	CcSEcCtD
Conjugated Estrogens—Alopecia—Docetaxel—melanoma	0.000184	0.00135	CcSEcCtD
Conjugated Estrogens—Mental disorder—Docetaxel—melanoma	0.000183	0.00133	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Carmustine—melanoma	0.000182	0.00133	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Carmustine—melanoma	0.000182	0.00133	CcSEcCtD
Conjugated Estrogens—Gastrointestinal pain—Temozolomide—melanoma	0.000182	0.00133	CcSEcCtD
Conjugated Estrogens—Malnutrition—Docetaxel—melanoma	0.000182	0.00133	CcSEcCtD
Conjugated Estrogens—Erythema—Docetaxel—melanoma	0.000182	0.00133	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Dactinomycin—melanoma	0.000182	0.00133	CcSEcCtD
Conjugated Estrogens—Dysgeusia—Docetaxel—melanoma	0.000178	0.0013	CcSEcCtD
Conjugated Estrogens—Urticaria—Temozolomide—melanoma	0.000177	0.00129	CcSEcCtD
Conjugated Estrogens—Asthenia—Dactinomycin—melanoma	0.000177	0.00129	CcSEcCtD
Conjugated Estrogens—SLCO2B1—lymph node—melanoma	0.000177	0.0103	CbGeAlD
Conjugated Estrogens—Body temperature increased—Temozolomide—melanoma	0.000176	0.00129	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Temozolomide—melanoma	0.000176	0.00129	CcSEcCtD
Conjugated Estrogens—Back pain—Docetaxel—melanoma	0.000176	0.00128	CcSEcCtD
Conjugated Estrogens—Muscle spasms—Docetaxel—melanoma	0.000175	0.00127	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Carmustine—melanoma	0.00017	0.00124	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Dactinomycin—melanoma	0.000169	0.00123	CcSEcCtD
Conjugated Estrogens—Vomiting—Bleomycin—melanoma	0.000168	0.00123	CcSEcCtD
Conjugated Estrogens—Rash—Bleomycin—melanoma	0.000167	0.00122	CcSEcCtD
Conjugated Estrogens—Dermatitis—Bleomycin—melanoma	0.000167	0.00122	CcSEcCtD
Conjugated Estrogens—Asthenia—Carmustine—melanoma	0.000166	0.00121	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Temozolomide—melanoma	0.000164	0.0012	CcSEcCtD
Conjugated Estrogens—Syncope—Docetaxel—melanoma	0.000163	0.00119	CcSEcCtD
Conjugated Estrogens—Palpitations—Docetaxel—melanoma	0.000161	0.00117	CcSEcCtD
Conjugated Estrogens—Asthenia—Temozolomide—melanoma	0.00016	0.00117	CcSEcCtD
Conjugated Estrogens—Loss of consciousness—Docetaxel—melanoma	0.00016	0.00117	CcSEcCtD
Conjugated Estrogens—Cough—Docetaxel—melanoma	0.000159	0.00116	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Carmustine—melanoma	0.000158	0.00115	CcSEcCtD
Conjugated Estrogens—Pruritus—Temozolomide—melanoma	0.000158	0.00115	CcSEcCtD
Conjugated Estrogens—Convulsion—Docetaxel—melanoma	0.000157	0.00115	CcSEcCtD
Conjugated Estrogens—Nausea—Bleomycin—melanoma	0.000157	0.00115	CcSEcCtD
Conjugated Estrogens—Vomiting—Dactinomycin—melanoma	0.000157	0.00114	CcSEcCtD
Conjugated Estrogens—ABCC4—lymph node—melanoma	0.000157	0.00914	CbGeAlD
Conjugated Estrogens—Rash—Dactinomycin—melanoma	0.000155	0.00113	CcSEcCtD
Conjugated Estrogens—Chest pain—Docetaxel—melanoma	0.000155	0.00113	CcSEcCtD
Conjugated Estrogens—Arthralgia—Docetaxel—melanoma	0.000155	0.00113	CcSEcCtD
Conjugated Estrogens—Myalgia—Docetaxel—melanoma	0.000155	0.00113	CcSEcCtD
Conjugated Estrogens—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000154	0.00112	CcSEcCtD
Conjugated Estrogens—Dizziness—Carmustine—melanoma	0.000153	0.00111	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Temozolomide—melanoma	0.000153	0.00111	CcSEcCtD
Conjugated Estrogens—ABCC2—lymph node—melanoma	0.000152	0.00885	CbGeAlD
Conjugated Estrogens—Oedema—Docetaxel—melanoma	0.000148	0.00108	CcSEcCtD
Conjugated Estrogens—Anaphylactic shock—Docetaxel—melanoma	0.000148	0.00108	CcSEcCtD
Conjugated Estrogens—Dizziness—Temozolomide—melanoma	0.000147	0.00108	CcSEcCtD
Conjugated Estrogens—Infection—Docetaxel—melanoma	0.000147	0.00108	CcSEcCtD
Conjugated Estrogens—Vomiting—Carmustine—melanoma	0.000147	0.00107	CcSEcCtD
Conjugated Estrogens—Nausea—Dactinomycin—melanoma	0.000146	0.00107	CcSEcCtD
Conjugated Estrogens—Shock—Docetaxel—melanoma	0.000146	0.00106	CcSEcCtD
Conjugated Estrogens—Rash—Carmustine—melanoma	0.000146	0.00106	CcSEcCtD
Conjugated Estrogens—Nervous system disorder—Docetaxel—melanoma	0.000145	0.00106	CcSEcCtD
Conjugated Estrogens—Dermatitis—Carmustine—melanoma	0.000145	0.00106	CcSEcCtD
Conjugated Estrogens—Tachycardia—Docetaxel—melanoma	0.000145	0.00106	CcSEcCtD
Conjugated Estrogens—Headache—Carmustine—melanoma	0.000145	0.00106	CcSEcCtD
Conjugated Estrogens—Skin disorder—Docetaxel—melanoma	0.000144	0.00105	CcSEcCtD
Conjugated Estrogens—Vomiting—Temozolomide—melanoma	0.000142	0.00103	CcSEcCtD
Conjugated Estrogens—Anorexia—Docetaxel—melanoma	0.000141	0.00103	CcSEcCtD
Conjugated Estrogens—Rash—Temozolomide—melanoma	0.000141	0.00103	CcSEcCtD
Conjugated Estrogens—Dermatitis—Temozolomide—melanoma	0.00014	0.00103	CcSEcCtD
Conjugated Estrogens—Ethinyl Estradiol—ABCB1—melanoma	0.00014	0.0313	CrCbGaD
Conjugated Estrogens—Headache—Temozolomide—melanoma	0.00014	0.00102	CcSEcCtD
Conjugated Estrogens—Hypotension—Docetaxel—melanoma	0.000139	0.00101	CcSEcCtD
Conjugated Estrogens—ESR1—lymph node—melanoma	0.000138	0.00805	CbGeAlD
Conjugated Estrogens—Nausea—Carmustine—melanoma	0.000137	0.001	CcSEcCtD
Conjugated Estrogens—ABCB1—retina—melanoma	0.000136	0.00793	CbGeAlD
Conjugated Estrogens—Musculoskeletal discomfort—Docetaxel—melanoma	0.000135	0.000986	CcSEcCtD
Conjugated Estrogens—Insomnia—Docetaxel—melanoma	0.000134	0.000979	CcSEcCtD
Conjugated Estrogens—ABCC1—lymph node—melanoma	0.000134	0.00779	CbGeAlD
Conjugated Estrogens—Paraesthesia—Docetaxel—melanoma	0.000133	0.000972	CcSEcCtD
Conjugated Estrogens—Nausea—Temozolomide—melanoma	0.000132	0.000967	CcSEcCtD
Conjugated Estrogens—Dyspnoea—Docetaxel—melanoma	0.000132	0.000965	CcSEcCtD
Conjugated Estrogens—Somnolence—Docetaxel—melanoma	0.000132	0.000962	CcSEcCtD
Conjugated Estrogens—Dyspepsia—Docetaxel—melanoma	0.000131	0.000953	CcSEcCtD
Conjugated Estrogens—Decreased appetite—Docetaxel—melanoma	0.000129	0.000941	CcSEcCtD
Conjugated Estrogens—Gastrointestinal disorder—Docetaxel—melanoma	0.000128	0.000934	CcSEcCtD
Conjugated Estrogens—Fatigue—Docetaxel—melanoma	0.000128	0.000933	CcSEcCtD
Conjugated Estrogens—Estrone—ALB—melanoma	0.000128	0.0285	CrCbGaD
Conjugated Estrogens—Pain—Docetaxel—melanoma	0.000127	0.000926	CcSEcCtD
Conjugated Estrogens—Constipation—Docetaxel—melanoma	0.000127	0.000926	CcSEcCtD
Conjugated Estrogens—Estrone—ABCB1—melanoma	0.000122	0.0272	CrCbGaD
Conjugated Estrogens—Gastrointestinal pain—Docetaxel—melanoma	0.000121	0.000885	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Docetaxel—melanoma	0.000117	0.000856	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Docetaxel—melanoma	0.000117	0.000856	CcSEcCtD
Conjugated Estrogens—ABCG2—lymph node—melanoma	0.000111	0.00645	CbGeAlD
Conjugated Estrogens—Hypersensitivity—Docetaxel—melanoma	0.000109	0.000797	CcSEcCtD
Conjugated Estrogens—ABCB1—mammalian vulva—melanoma	0.000109	0.00635	CbGeAlD
Conjugated Estrogens—Asthenia—Docetaxel—melanoma	0.000106	0.000777	CcSEcCtD
Conjugated Estrogens—Pruritus—Docetaxel—melanoma	0.000105	0.000766	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Docetaxel—melanoma	0.000101	0.000741	CcSEcCtD
Conjugated Estrogens—Dizziness—Docetaxel—melanoma	9.81e-05	0.000716	CcSEcCtD
Conjugated Estrogens—Estradiol—ALB—melanoma	9.69e-05	0.0216	CrCbGaD
Conjugated Estrogens—Vomiting—Docetaxel—melanoma	9.43e-05	0.000688	CcSEcCtD
Conjugated Estrogens—Rash—Docetaxel—melanoma	9.35e-05	0.000682	CcSEcCtD
Conjugated Estrogens—Dermatitis—Docetaxel—melanoma	9.34e-05	0.000682	CcSEcCtD
Conjugated Estrogens—Headache—Docetaxel—melanoma	9.29e-05	0.000678	CcSEcCtD
Conjugated Estrogens—Estradiol—ABCB1—melanoma	9.25e-05	0.0206	CrCbGaD
Conjugated Estrogens—Nausea—Docetaxel—melanoma	8.81e-05	0.000643	CcSEcCtD
Conjugated Estrogens—ABCB1—head—melanoma	7.79e-05	0.00454	CbGeAlD
Conjugated Estrogens—ABCB1—lymph node—melanoma	5.45e-05	0.00318	CbGeAlD
Conjugated Estrogens—SLCO1B3—Metabolism—PIK3CD—melanoma	7.48e-06	5.61e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—SYK—melanoma	7.47e-06	5.61e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PLCB4—melanoma	7.46e-06	5.6e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—NOS2—melanoma	7.41e-06	5.57e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—PPARG—melanoma	7.41e-06	5.56e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—ALB—melanoma	7.38e-06	5.54e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—NOTCH1—melanoma	7.34e-06	5.51e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—ABCB1—melanoma	7.34e-06	5.51e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—ITGAV—melanoma	7.33e-06	5.51e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—NGFR—melanoma	7.33e-06	5.51e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—AKT3—melanoma	7.33e-06	5.51e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—BSG—melanoma	7.32e-06	5.5e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—SDHD—melanoma	7.32e-06	5.5e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—CSPG4—melanoma	7.32e-06	5.5e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—PRKCA—melanoma	7.3e-06	5.48e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—ERCC2—melanoma	7.24e-06	5.43e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—CD80—melanoma	7.19e-06	5.4e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	7.19e-06	5.4e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—APC—melanoma	7.18e-06	5.39e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—KIT—melanoma	7.18e-06	5.39e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Gene Expression—NOTCH1—melanoma	7.11e-06	5.34e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—EGF—melanoma	7.1e-06	5.33e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—GPAM—melanoma	7.09e-06	5.33e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PIP4K2A—melanoma	7.01e-06	5.27e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—SLC6A11—melanoma	7.01e-06	5.27e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	7.01e-06	5.26e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	6.95e-06	5.22e-05	CbGpPWpGaD
Conjugated Estrogens—COMT—Metabolism—PTEN—melanoma	6.89e-06	5.18e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—MTAP—melanoma	6.82e-06	5.12e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Hemostasis—AKT1—melanoma	6.79e-06	5.1e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—SOCS1—melanoma	6.79e-06	5.1e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—VCAN—melanoma	6.79e-06	5.1e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—S100B—melanoma	6.77e-06	5.08e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—PRKCA—melanoma	6.76e-06	5.07e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—BRAF—melanoma	6.75e-06	5.07e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—PIK3CD—melanoma	6.75e-06	5.07e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Gene Expression—PPARG—melanoma	6.71e-06	5.04e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—ERCC2—melanoma	6.7e-06	5.03e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—PIK3CG—melanoma	6.68e-06	5.02e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—ALB—melanoma	6.66e-06	5e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—PIK3CB—melanoma	6.52e-06	4.89e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—ERBB4—melanoma	6.48e-06	4.86e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—PTGS2—melanoma	6.46e-06	4.85e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—PPARG—melanoma	6.45e-06	4.84e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—CDKN2B—melanoma	6.42e-06	4.82e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—MAP2K1—melanoma	6.35e-06	4.77e-05	CbGpPWpGaD
Conjugated Estrogens—SLC10A1—Metabolism—PIK3CA—melanoma	6.34e-06	4.76e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—PIK3CD—melanoma	6.31e-06	4.74e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	6.31e-06	4.74e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—CD86—melanoma	6.21e-06	4.66e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—EDN1—melanoma	6.16e-06	4.63e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PHGDH—melanoma	6.08e-06	4.57e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—LUM—melanoma	6.08e-06	4.57e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—FGF2—melanoma	6.04e-06	4.54e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PLA2G6—melanoma	6.03e-06	4.53e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—FGF1—melanoma	6.02e-06	4.52e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—CSF2—melanoma	6.02e-06	4.52e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—PIK3CG—melanoma	6.01e-06	4.52e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	5.99e-06	4.5e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—HPSE—melanoma	5.96e-06	4.48e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—E2F1—melanoma	5.89e-06	4.42e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—PIK3CB—melanoma	5.88e-06	4.42e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—PIK3CD—melanoma	5.87e-06	4.41e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	5.87e-06	4.41e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—CUBN—melanoma	5.85e-06	4.39e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—PDGFRA—melanoma	5.83e-06	4.38e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—PTGS2—melanoma	5.83e-06	4.38e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—PPARG—melanoma	5.8e-06	4.36e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—ALB—melanoma	5.8e-06	4.35e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—ITGB3—melanoma	5.77e-06	4.33e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—PRKCA—melanoma	5.77e-06	4.33e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—CYP17A1—melanoma	5.73e-06	4.3e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—PIK3CG—melanoma	5.71e-06	4.29e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—SPP1—melanoma	5.66e-06	4.25e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—MDM2—melanoma	5.65e-06	4.25e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—SDHD—melanoma	5.65e-06	4.24e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—CSPG4—melanoma	5.65e-06	4.24e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—BSG—melanoma	5.65e-06	4.24e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—MAP2K2—melanoma	5.64e-06	4.24e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—PTEN—melanoma	5.63e-06	4.23e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—ERBB2—melanoma	5.58e-06	4.19e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—PPARG—melanoma	5.52e-06	4.14e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—PIK3CB—melanoma	5.5e-06	4.13e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—CD4—melanoma	5.49e-06	4.12e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—GPAM—melanoma	5.47e-06	4.11e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—PTGS2—melanoma	5.45e-06	4.09e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—VCAN—melanoma	5.42e-06	4.07e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—GNA11—melanoma	5.41e-06	4.06e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—TERT—melanoma	5.37e-06	4.03e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—RAC1—melanoma	5.35e-06	4.02e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	5.3e-06	3.98e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—FASN—melanoma	5.29e-06	3.97e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—PIK3CG—melanoma	5.29e-06	3.97e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—PIK3CD—melanoma	5.29e-06	3.97e-05	CbGpPWpGaD
Conjugated Estrogens—ESR2—Gene Expression—AKT1—melanoma	5.26e-06	3.95e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—ALB—melanoma	5.22e-06	3.92e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—SLC5A5—melanoma	5.2e-06	3.91e-05	CbGpPWpGaD
Conjugated Estrogens—SLC10A1—Metabolism—AKT1—melanoma	5.18e-06	3.89e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—CDKN1B—melanoma	5.16e-06	3.88e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—HIF1A—melanoma	5.13e-06	3.85e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	5.13e-06	3.85e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—PIK3CB—melanoma	5.12e-06	3.84e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—PPARG—melanoma	5.11e-06	3.83e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—PTEN—melanoma	5.08e-06	3.82e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—PTGS2—melanoma	5.07e-06	3.81e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—GNAQ—melanoma	5.03e-06	3.77e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—CD44—melanoma	5.03e-06	3.77e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—PIK3CD—melanoma	5.02e-06	3.77e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—ALB—melanoma	4.96e-06	3.72e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	4.95e-06	3.72e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—KDR—melanoma	4.91e-06	3.69e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—CTNNB1—melanoma	4.88e-06	3.66e-05	CbGpPWpGaD
Conjugated Estrogens—COMT—Metabolism—PIK3CA—melanoma	4.86e-06	3.65e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—CYP1B1—melanoma	4.82e-06	3.62e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—CDKN1A—melanoma	4.76e-06	3.58e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—PTEN—melanoma	4.75e-06	3.57e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—FN1—melanoma	4.72e-06	3.55e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PLA2G6—melanoma	4.65e-06	3.5e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—PIK3CD—melanoma	4.65e-06	3.49e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—NOTCH1—melanoma	4.62e-06	3.47e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—PIK3CB—melanoma	4.61e-06	3.46e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—ALB—melanoma	4.59e-06	3.45e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—CYP17A1—melanoma	4.57e-06	3.43e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—PTGS2—melanoma	4.57e-06	3.43e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—CD80—melanoma	4.53e-06	3.4e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—KIT—melanoma	4.52e-06	3.39e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—PIK3CG—melanoma	4.52e-06	3.39e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—APC—melanoma	4.52e-06	3.39e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	4.51e-06	3.39e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—EGF—melanoma	4.47e-06	3.36e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	4.45e-06	3.34e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—PTEN—melanoma	4.42e-06	3.32e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—PIK3CB—melanoma	4.38e-06	3.29e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—PTGS2—melanoma	4.34e-06	3.26e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—GNA11—melanoma	4.32e-06	3.24e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—STAT3—melanoma	4.25e-06	3.19e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—BRAF—melanoma	4.25e-06	3.19e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—NRAS—melanoma	4.24e-06	3.18e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—FASN—melanoma	4.22e-06	3.17e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—VCAN—melanoma	4.18e-06	3.14e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—SLC5A5—melanoma	4.15e-06	3.12e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—IGF1—melanoma	4.14e-06	3.11e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—MAPK3—melanoma	4.06e-06	3.05e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—PIK3CB—melanoma	4.05e-06	3.04e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—PTGS2—melanoma	4.02e-06	3.02e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—GNAQ—melanoma	4.01e-06	3.01e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—CD44—melanoma	4.01e-06	3.01e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—MAP2K1—melanoma	4e-06	3e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—PTEN—melanoma	3.98e-06	2.99e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—PIK3CD—melanoma	3.97e-06	2.98e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—PIK3CA—melanoma	3.97e-06	2.98e-05	CbGpPWpGaD
Conjugated Estrogens—COMT—Metabolism—AKT1—melanoma	3.97e-06	2.98e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—MYC—melanoma	3.95e-06	2.97e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Gene Expression—MAPK3—melanoma	3.93e-06	2.95e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	3.93e-06	2.95e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	3.89e-06	2.92e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—MAPK1—melanoma	3.87e-06	2.9e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—EGFR—melanoma	3.86e-06	2.9e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—CYP1B1—melanoma	3.85e-06	2.89e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Gene Expression—MYC—melanoma	3.83e-06	2.87e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—FGF2—melanoma	3.81e-06	2.86e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—PTEN—melanoma	3.78e-06	2.84e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—PRKCA—melanoma	3.65e-06	2.74e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—KRAS—melanoma	3.65e-06	2.74e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—ERCC2—melanoma	3.62e-06	2.72e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—PIK3CA—melanoma	3.58e-06	2.69e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—MDM2—melanoma	3.56e-06	2.67e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—CYP17A1—melanoma	3.53e-06	2.65e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—ERBB2—melanoma	3.51e-06	2.64e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—PTEN—melanoma	3.5e-06	2.63e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—PIK3CB—melanoma	3.46e-06	2.6e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	3.4e-06	2.55e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—PIK3CA—melanoma	3.35e-06	2.52e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—GNA11—melanoma	3.33e-06	2.5e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—CXCL8—melanoma	3.33e-06	2.5e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—FASN—melanoma	3.26e-06	2.45e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—CDKN1B—melanoma	3.25e-06	2.44e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—AKT1—melanoma	3.25e-06	2.44e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—SLC5A5—melanoma	3.21e-06	2.41e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—CASP3—melanoma	3.19e-06	2.39e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—IL2—melanoma	3.18e-06	2.39e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—ABCB1—melanoma	3.17e-06	2.38e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—PIK3CA—melanoma	3.12e-06	2.34e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—HRAS—melanoma	3.1e-06	2.33e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—CCND1—melanoma	3.1e-06	2.33e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—GNAQ—melanoma	3.1e-06	2.33e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—CD44—melanoma	3.1e-06	2.33e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—CTNNB1—melanoma	3.07e-06	2.31e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—MMP9—melanoma	3.01e-06	2.26e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—CDKN1A—melanoma	3e-06	2.25e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—PTEN—melanoma	2.99e-06	2.25e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—NFKB1—melanoma	2.98e-06	2.24e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—IL6—melanoma	2.97e-06	2.23e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—CYP1B1—melanoma	2.97e-06	2.23e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—AKT1—melanoma	2.93e-06	2.2e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PRKCA—melanoma	2.92e-06	2.19e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—ERCC2—melanoma	2.89e-06	2.17e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—PIK3CG—melanoma	2.86e-06	2.15e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—PIK3CA—melanoma	2.81e-06	2.11e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—PPARG—melanoma	2.76e-06	2.07e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—AKT1—melanoma	2.74e-06	2.06e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—VEGFA—melanoma	2.7e-06	2.03e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—STAT3—melanoma	2.68e-06	2.01e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—NRAS—melanoma	2.67e-06	2.01e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—PIK3CA—melanoma	2.67e-06	2e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Gene Expression—AKT1—melanoma	2.65e-06	1.99e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—MAPK3—melanoma	2.56e-06	1.92e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—AKT1—melanoma	2.55e-06	1.91e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—PIK3CD—melanoma	2.51e-06	1.89e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—MYC—melanoma	2.49e-06	1.87e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—ALB—melanoma	2.48e-06	1.86e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—PIK3CA—melanoma	2.47e-06	1.86e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—ABCB1—melanoma	2.45e-06	1.84e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—MAPK1—melanoma	2.43e-06	1.83e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—EGFR—melanoma	2.43e-06	1.83e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.4e-06	1.8e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—KRAS—melanoma	2.3e-06	1.73e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—AKT1—melanoma	2.29e-06	1.72e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PIK3CG—melanoma	2.28e-06	1.71e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PRKCA—melanoma	2.25e-06	1.69e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—ERCC2—melanoma	2.23e-06	1.68e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PPARG—melanoma	2.2e-06	1.66e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—PIK3CB—melanoma	2.19e-06	1.65e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—AKT1—melanoma	2.18e-06	1.64e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—PTGS2—melanoma	2.17e-06	1.63e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—PIK3CA—melanoma	2.11e-06	1.59e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—TP53—melanoma	2.04e-06	1.53e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—AKT1—melanoma	2.02e-06	1.52e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PIK3CD—melanoma	2.01e-06	1.51e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—ALB—melanoma	1.98e-06	1.49e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—HRAS—melanoma	1.95e-06	1.47e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—PTEN—melanoma	1.89e-06	1.42e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—IL6—melanoma	1.87e-06	1.4e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PIK3CG—melanoma	1.76e-06	1.32e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PIK3CB—melanoma	1.75e-06	1.31e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PTGS2—melanoma	1.73e-06	1.3e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—AKT1—melanoma	1.73e-06	1.3e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PPARG—melanoma	1.7e-06	1.28e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PIK3CD—melanoma	1.55e-06	1.16e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—ALB—melanoma	1.53e-06	1.15e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PTEN—melanoma	1.51e-06	1.14e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PIK3CB—melanoma	1.35e-06	1.01e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PTGS2—melanoma	1.34e-06	1e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—PIK3CA—melanoma	1.34e-06	1e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PTEN—melanoma	1.17e-06	8.76e-06	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—AKT1—melanoma	1.09e-06	8.2e-06	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PIK3CA—melanoma	1.07e-06	8.01e-06	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—AKT1—melanoma	8.71e-07	6.54e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PIK3CA—melanoma	8.23e-07	6.18e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—AKT1—melanoma	6.73e-07	5.05e-06	CbGpPWpGaD
